Lv47
644 积分 2025-08-11 加入
Interleukin-18 Secreting Autologous Anti-CD19 CAR T-Cells (huCART19-IL18) in Patients with Non-Hodgkin Lymphomas Relapsed or Refractory to Prior CAR T-Cell Therapy
2天前
求助中
Interleukin-18 Secreting Autologous Anti-CD19 CAR T-Cells (huCART19-IL18) in Patients with Non-Hodgkin Lymphomas Relapsed or Refractory to Prior CAR T-Cell Therapy
2天前
已完结
Benefit from huCAR19-IL18 cells in patients with CD19+ lymphomas after CAR T cells
2天前
已完结
CAR-T therapy in solid tumors
3天前
已完结
Small-molecule control of CAR T cells
3天前
已完结
Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
3天前
已完结
CAR T cell–induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade
4天前
已完结
CAR immune cells: design principles, resistance and the next generation
4天前
已完结
IL-18 revives dysfunctional CAR-T cells
4天前
已完结
CAR T-cell therapy in autoimmune diseases
5天前
已完结
皖公网安备34019202002308
